http://www.fsdcme.org en-us FSDcme.org - The France Foundation FSDcme.org (Female Sexual Dysfunction) houses a comprehensive national continuing medical education curriculum that addresses the epidemiology and diagnosis of hypoactive sexual desire disorder (HSDD), strategies to facilitate communication with patients about female sexual dysfunction, and increased awareness of the management options for HSDD and other female sexual dysfunctions. Female sexual dysfunction is relatively common with over 40% of women reporting difficulty with sexual desire, arousal, orgasm, or pain according to recent studies. Based on the definition derived from the American Psychiatric Association DSM-IV-TR and the American Foundation for Urologic Disease, hypoactive sexual desire disorder (HSDD) is a persistent or recurrent deficiency of sexual fantasies, thoughts and/or desire for or receptivity to sexual activity, which causes personal distress. The prevalence of HSDD in adult women in the United States is ~10% based on data from the PRESIDE (Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking) study. Sexual dysfunction negatively impacts physical and emotional satisfaction and overall quality of life, therefore incorporation of sexual health into routine female healthcare is warranted. FSDcme.org mpereira@francefoundation.com Copyright 2010 The France Foundation Wed, 14 Oct 2010 03:01:00 EDT Wed, 14 Oct 2010 03:02:00 EDT 60 FSDcme.org http://www.fsdcme.org/podcast/FSDcme_06.mp3 http://www.fsdcme.org/podcast/FSDcme_06.mp3 Describe nonpharmacological interventions and alternative therapies for HSDD Review the investigational pharmacological and nonpharmacological management options for HSDD CME - Peer-to-Peer Dialogue Wed, 14 Oct 2010 03:02:00 EDT 00:12:36 CME, Continuing Education, Education, Credit, Webinar, Podcast, AMA PRA Category 1 Credit, HSDD, FSD, dysfunction FSDcme.org http://www.fsdcme.org/podcast/FSDcme_05.mp3 http://www.fsdcme.org/podcast/FSDcme_05.mp3 Discuss the safety and efficacy of pharmacological therapies for the management of HSDD Review the investigational pharmacological and nonpharmacological management options for HSDD CME - Peer-to-Peer Dialogue Wed, 14 Oct 2010 03:02:00 EDT 00:17:00 CME, Continuing Education, Education, Credit, Webinar, Podcast, AMA PRA Category 1 Credit, HSDD, FSD, dysfunction FSDcme.org http://www.fsdcme.org/podcast/FSDcme_04.mp3 http://www.fsdcme.org/podcast/FSDcme_04.mp3 What are the patient and physician barriers that complicate the identification and management of HSDD? Demonstrate an ability to effectively engage female patients about their sexual health and its relevance to their overall health status CME - Peer-to-Peer Dialogue Wed, 14 Oct 2010 03:02:00 EDT 00:15:05 CME, Continuing Education, Education, Credit, Webinar, Podcast, AMA PRA Category 1 Credit, HSDD, FSD, dysfunction FSDcme.org http://www.fsdcme.org/podcast/FSDcme_03.mp3 http://www.fsdcme.org/podcast/FSDcme_03.mp3 Discuss the recognition and diagnosis of HSDD Identify the importance of being able to recognize and diagnose HSDD in the context of its potential to cause distress, social withdrawal, and relationship conflict CME - Peer-to-Peer Dialogue Wed, 14 Oct 2010 03:02:00 EDT 00:14:10 CME, Continuing Education, Education, Credit, Webinar, Podcast, AMA PRA Category 1 Credit, HSDD, FSD, dysfunction FSDcme.org http://www.fsdcme.org/podcast/FSDcme_02.mp3 http://www.fsdcme.org/podcast/FSDcme_02.mp3 Discuss the medical, pharmacological, psychological, and social factors that may contribute to HSDD Identify the importance of being able to recognize and diagnose HSDD in the context of its potential to cause distress, social withdrawal, and relationship conflict CME - Peer-to-Peer Dialogue Wed, 14 Oct 2010 03:02:00 EDT 00:11:38 CME, Continuing Education, Education, Credit, Webinar, Podcast, AMA PRA Category 1 Credit, HSDD, FSD, dysfunction FSDcme.org http://www.fsdcme.org/podcast/FSDcme_01.mp3 http://www.fsdcme.org/podcast/FSDcme_01.mp3 Discuss types of female sexual dysfunction, including prevalence and associated health burden Describe the classification and types of female sexual dysfunction, and the latest evidence related to the incidence, prevalence, and overall health burden of HSDD among women of all ages CME - Peer-to-Peer Dialogue Wed, 14 Oct 2010 03:02:00 EDT 00:13:07 CME, Continuing Education, Education, Credit, Webinar, Podcast, AMA PRA Category 1 Credit, HSDD, FSD, dysfunction